AC Immune (ACIU) Intangibles (2021 - 2025)
AC Immune (ACIU) reported Intangibles of $63.1 million for Q4 2025, up 9.61% year-over-year from $57.6 million in Q4 2024, and little changed on a QoQ basis from $63.0 million in Q3 2025.
AC Immune (ACIU) has 5 years of Intangibles data on file, last reported at $63.1 million in Q4 2025.
- Quarterly Intangibles rose 9.61% year-over-year to $63.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $63.1 million (up 9.61% YoY) and the FY2025 annual result came in at $60.8 million, up 5.66% from the prior year.
- Intangibles held at $63.1 million in Q4 2025 per ACIU's latest filing, from $63.0 million in the prior quarter.
- Across five years, Intangibles topped out at $56.8 billion in Q4 2023 and bottomed at $52.2 million in Q3 2022.
- The 5-year median for Intangibles is $57.1 million (2023), against an average of $6.6 billion.
- The widest annual swing landed in 2022, when Intangibles plunged 99.9%; it then surged 108506.04% in 2023.
- Tracing ACIU's Intangibles over 5 years: stood at $54.7 billion in 2021, then sank by 99.9% to $52.3 million in 2022, then surged by 108506.04% to $56.8 billion in 2023, then sank by 99.9% to $57.6 million in 2024, then grew by 9.61% to $63.1 million in 2025.
- Per Business Quant, the three latest ACIU Intangibles figures stand at $63.1 million (Q4 2025), $63.0 million (Q3 2025), and $60.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.08 Mn |
| Sep 30, 2025 | 63.03 Mn |
| Jun 30, 2025 | 60.90 Mn |
| Mar 31, 2025 | 56.08 Mn |
| Dec 31, 2024 | 57.55 Mn |
| Sep 30, 2024 | 58.19 Mn |
| Jun 30, 2024 | 55.75 Mn |
| Mar 31, 2024 | 57.76 Mn |
| Dec 31, 2023 | 56.84 Bn |
| Sep 30, 2023 | 57.08 Mn |
| Jun 30, 2023 | 56.07 Mn |
| Mar 31, 2023 | 54.51 Mn |
| Dec 31, 2022 | 52.33 Mn |
| Sep 30, 2022 | 52.20 Mn |
| Jun 30, 2022 | 52.35 Mn |
| Mar 31, 2022 | 54.59 Mn |
| Dec 31, 2021 | 54.68 Bn |